Temafloxacin in the treatment of male urethritis

Keizo Suzuki; Masaki Horiba; Toshiyuki Tanaka; Masahiro Yonezu; Yorio Naide; Hideo Hibi; Shin Ichi Ando; Koichi Ishiguro; Haruyoshi Asano; Kiyohito Ishikawa

doi:10.11250/chemotherapy1953.41.Supplement5_843

Temafloxacin in the treatment of male urethritis

Keizo Suzuki
, Masaki Horiba
, Toshiyuki Tanaka
, Masahiro Yonezu
, Yorio Naide
, Hideo Hibi
, Shin Ichi Ando
, Koichi Ishiguro
, Haruyoshi Asano
, Kiyohito Ishikawa

Research output: Contribution to journal › Article › peer-review

Abstract

Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

Original language	English
Pages (from-to)	843-845
Number of pages	3
Journal	CHEMOTHERAPY
Volume	41
DOIs	https://doi.org/10.11250/chemotherapy1953.41.Supplement5_843
Publication status	Published - 1993
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Pharmacology (medical)
Infectious Diseases
Pharmacology
Drug Discovery
Oncology

Access to Document

10.11250/chemotherapy1953.41.Supplement5_843

Cite this

@article{c67ff6311fc7473c8a6cac2ba90fc78c,

title = "Temafloxacin in the treatment of male urethritis",

abstract = "Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300\textasciitilde{}600 mg a day for 4\textasciitilde{}28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100\%), NGU 3/3 (100\%), and GCU/NGU 4/4 (100\%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.",

author = "Keizo Suzuki and Masaki Horiba and Toshiyuki Tanaka and Masahiro Yonezu and Yorio Naide and Hideo Hibi and Ando, \{Shin Ichi\} and Koichi Ishiguro and Haruyoshi Asano and Kiyohito Ishikawa",

year = "1993",

doi = "10.11250/chemotherapy1953.41.Supplement5\_843",

language = "English",

volume = "41",

pages = "843--845",

journal = "CHEMOTHERAPY",

issn = "0009-3165",

}

TY - JOUR

T1 - Temafloxacin in the treatment of male urethritis

AU - Suzuki, Keizo

AU - Horiba, Masaki

AU - Tanaka, Toshiyuki

AU - Yonezu, Masahiro

AU - Naide, Yorio

AU - Hibi, Hideo

AU - Ando, Shin Ichi

AU - Ishiguro, Koichi

AU - Asano, Haruyoshi

AU - Ishikawa, Kiyohito

PY - 1993

Y1 - 1993

N2 - Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

AB - Twenty-one adult male outpatients with gonococcal (GUC) or chlamydial (NGU), and gonococcal/chlamydial (GCU/NGU) urethritis were treated with temafloxacin. It was given at a dose of 300~600 mg a day for 4~28 days (8.7 ±5.7 days). Eradication of the organisms was obtained for GCU in 14/14 (100%), NGU 3/3 (100%), and GCU/NGU 4/4 (100%). Clinically, the drug proved to be highly effective for male urethritis, and it was well tolerated by all patients treated.

UR - https://www.scopus.com/pages/publications/0027761823

UR - https://www.scopus.com/pages/publications/0027761823#tab=citedBy

U2 - 10.11250/chemotherapy1953.41.Supplement5_843

DO - 10.11250/chemotherapy1953.41.Supplement5_843

M3 - Article

AN - SCOPUS:0027761823

SN - 0009-3165

VL - 41

SP - 843

EP - 845

JO - CHEMOTHERAPY

JF - CHEMOTHERAPY

ER -

Temafloxacin in the treatment of male urethritis

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this